Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1675]

SABCS 2022: Adding capivasertib to fulvestrant improves progression-free survival in patients with advanced hormone receptor-positive breast cancer

SABCS 2022: Adding capivasertib to fulvestrant improves progression-free survival in patients with advanced...

Hospital parking fees contribute to financial toxicity for cancer patients

Hospital parking fees contribute to financial toxicity for cancer patients

MicroRNAs can help predict disease recurrence in patients with breast cancer

MicroRNAs can help predict disease recurrence in patients with breast cancer

Webinar: Quality management in breast cancer surgery

Webinar: Quality management in breast cancer surgery

Researchers identify a subset of patients with early melanoma who face a very low risk of dying from the disease

Researchers identify a subset of patients with early melanoma who face a very low risk of dying from the disease

Shorter course of radiation therapy yields comparable results for patients with non-metastatic soft tissue sarcoma

Shorter course of radiation therapy yields comparable results for patients with non-metastatic soft tissue sarcoma

NCCN working with Medlive to advance high-quality cancer care in China and worldwide

NCCN working with Medlive to advance high-quality cancer care in China and worldwide

Pancreatic cancer could be diagnosed up to three years earlier

Pancreatic cancer could be diagnosed up to three years earlier

Deep learning-based virtual staining of tissue facilitates rapid assessment of breast cancer biomarker

Deep learning-based virtual staining of tissue facilitates rapid assessment of breast cancer biomarker

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

More from ecancer